Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

SBTX

Silverback Therapeutics, Inc.

Healthcare

Set alert

Price alert · SBTX

All alert types
5.87 0.00 0.00%
As of Nov 9, 2022
5.82 Day range 6.15

52-week range unavailable

Open
5.82
Prev close
5.87
Mkt cap
211.66M
Vol
116.69K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
5.82
High
6.15
Forward P/E
-2.76
Beta
0.00
Short ratio
5.20
Inst. own
78.61%
Dividend
0.00
Ex-div date
Earnings
Nov 2, 2022
50-d avg
5.39
200-d avg
4.37
1y target
5.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for SBTX has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-1.83 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -3.4×
FY 2018: -47.2×FY 2019: -34.7×FY 2020: -1509×FY 2021: -9.5×FY 2022: -6.7×FY 2023: -10.3×FY 2024: 71.2×FY 2025: -3.4×
FY 2018 5y median -6.7× FY 2025
P/S 6.9×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 90.2×FY 2021: 34.9×FY 2022: 178×FY 2023: 18630×FY 2024: 6.4×FY 2025: 6.9×
FY 2018 5y median 34.9× FY 2025
P/B 5.1×
FY 2018: 45.4×FY 2019: -148×FY 2020: 224×FY 2021: -6.1×FY 2022: 0.9×FY 2023: 2.4×FY 2024: 2.2×FY 2025: 5.1×
FY 2018 5y median 2.2× FY 2025
P/FCF -3.4×
FY 2018: -47.7×FY 2019: -43.5×FY 2020: 197×FY 2021: -10.9×FY 2022: -5.8×FY 2023: -9.4×FY 2024: 43.8×FY 2025: -3.4×
FY 2018 5y median -5.8× FY 2025
EV/EBITDA 393×
FY 2018: -48.2×FY 2019: -37.0×FY 2020: -3442×FY 2021: -7.3×FY 2022: -0.7×FY 2023: -7.2×FY 2024: -180×FY 2025: 393×
FY 2018 5y median -7.2× FY 2025
EV/Sales 6.4×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 89.3×FY 2021: 25.7×FY 2022: 18.6×FY 2023: 16274×FY 2024: 5.8×FY 2025: 6.4×
FY 2018 5y median 18.6× FY 2025
FCF Yield -29.6%
FY 2018: -2.1%FY 2019: -2.3%FY 2020: 0.5%FY 2021: -9.2%FY 2022: -17.2%FY 2023: -10.6%FY 2024: 2.3%FY 2025: -29.6%
FY 2018 5y median -10.6% FY 2025

Profitability

Gross Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 21.1%FY 2021: -268.2%FY 2022: -1200.9%FY 2023: -66786.7%FY 2024: 98.9%FY 2025: 0.0%
FY 2018 5y median -268.2% FY 2025
Operating Margin -212.9%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: -2.6%FY 2021: -353.3%FY 2022: -2698.8%FY 2023: -225066.7%FY 2024: -3.5%FY 2025: -212.9%
FY 2018 5y median -353.3% FY 2025
Net Margin -203.3%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: -6.0%FY 2021: -367.7%FY 2022: -2635.4%FY 2023: -181216.7%FY 2024: 9.0%FY 2025: -203.3%
FY 2018 5y median -367.7% FY 2025
ROE -149.9%
FY 2018: -96.6%FY 2019: 427.8%FY 2020: -14.8%FY 2021: 64.7%FY 2022: -12.7%FY 2023: -23.6%FY 2024: 3.1%FY 2025: -149.9%
FY 2018 5y median -12.7% FY 2025
ROIC -62.2%
FY 2018: -70.6%FY 2019: -240.3%FY 2020: -2.3%FY 2021: -34.2%FY 2022: -12.8%FY 2023: -29.2%FY 2024: -0.9%FY 2025: -62.2%
FY 2018 5y median -29.2% FY 2025
ROA -52.3%
FY 2018: -63.8%FY 2019: -153.2%FY 2020: -4.0%FY 2021: -32.9%FY 2022: -12.3%FY 2023: -23.3%FY 2024: 2.3%FY 2025: -52.3%
FY 2018 5y median -23.3% FY 2025

Growth (YoY)

Revenue -5.5%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -69.1%FY 2022: -76.1%FY 2023: -97.7%FY 2024: 297063.3%FY 2025: -5.5%
FY 2018 FY 2025
Operating Income -5720.6%
FY 2018: 0.0%FY 2019: -31.4%FY 2020: 98.1%FY 2021: -4048.0%FY 2022: -82.6%FY 2023: -90.1%FY 2024: 95.4%FY 2025: -5720.6%
FY 2018 FY 2025
EPS (diluted) -2327.9%
FY 2018: 0.0%FY 2019: -35.8%FY 2020: 95.7%FY 2021: -2180.1%FY 2022: -24.3%FY 2023: 34.5%FY 2024: 113.7%FY 2025: -2327.9%
FY 2018 FY 2025
Free Cash Flow -1418.5%
FY 2018: 0.0%FY 2019: -9.6%FY 2020: 142.9%FY 2021: -316.0%FY 2022: -128.6%FY 2023: -47.6%FY 2024: 121.8%FY 2025: -1418.5%
FY 2018 FY 2025

Financial Health

Current Ratio 7.3×
FY 2018: 4.0×FY 2019: 0.6×FY 2020: 3.2×FY 2021: 7.4×FY 2022: 51.0×FY 2023: 96.9×FY 2024: 14.3×FY 2025: 7.3×
FY 2018 5y median 14.3× FY 2025
Quick Ratio 7.1×
FY 2018: 4.0×FY 2019: 0.6×FY 2020: 3.2×FY 2021: 7.4×FY 2022: 51.0×FY 2023: 96.9×FY 2024: 14.0×FY 2025: 7.1×
FY 2018 5y median 14.0× FY 2025
Debt / Equity 0.0×
FY 2018: 0.4×FY 2019: -2.8×FY 2020: 1.4×FY 2021: -0.3×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA -30.2×
FY 2018: 0.7×FY 2019: -0.3×FY 2020: 31.3×FY 2021: 2.7×FY 2022: 6.2×FY 2023: 1.0×FY 2024: 17.7×FY 2025: -30.2×
FY 2018 5y median 2.7× FY 2025
Interest Coverage 69.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: -16.2×FY 2021: -184×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 69.0×
FY 2018 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31